Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ12,14 prostamide J2
Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ12,14 prostamide J2 |
|
https://doi.org/10.18632/oncotarget.27856
Ahmed Elhassanny,
Rene Escobedo,
Daniel Ladin,
Colin Burns,
and Rukiyah Van Dross
|
| 4788-4802 |
Reduction of T-Box 15 gene expression in tumor tissue is a prognostic biomarker for patients with hepatocellular carcinoma
Reduction of T-Box 15 gene expression in tumor tissue is a prognostic biomarker for patients with hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.27852
Yuji Morine,
Tohru Utsunomiya,
Yu Saito,
Shinichiro Yamada,
Satoru Imura,
Tetsuya Ikemoto,
Akihiro Kitagawa,
Yuta Kobayashi,
Seiichiro Takao,
Keisuke Kosai,
Koshi Mimori,
Yasuhito Tanaka,
and Mitsuo Shimada
|
| 4803-4812 |
Gastrointestinal stromal tumors (GISTs) and synchronous intra-abdominal malignancies: case series of a single institution’s experience
Gastrointestinal stromal tumors (GISTs) and synchronous intra-abdominal malignancies: case series of a single institution’s experience |
|
https://doi.org/10.18632/oncotarget.27853
Alexandros Diamantis,
Athina A. Samara,
Dimitrios Symeonidis,
Ioannis Baloyiannis,
Dionysia Vasdeki,
Maria Tolia,
Georgios Volakakis,
Georgios Mavrovounis,
and Konstantinos Tepetes
|
| 4813-4821 |
Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma
Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma |
|
https://doi.org/10.18632/oncotarget.27850
Hector A. Cuello,
Gretel M. Ferreira,
Cynthia A. Gulino,
Alejandro Gomez Toledo,
Valeria I. Segatori,
and Mariano R. Gabri
|
| 4822-4835 |
Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation |
|
https://doi.org/10.18632/oncotarget.27848
Karam Khaddour,
Joshua Dowling,
Jiayi Huang,
Martha Council,
David Chen,
Lynn Cornelius,
Tanner Johanns,
Sonika Dahiya,
and George Ansstas
|
| 4836-4844 |
Correction: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer
Correction: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer |
|
https://doi.org/10.18632/oncotarget.27740
Shuai Zhang,
Dehai Che,
Fang Yang,
Chunling Chi,
Hongxue Meng,
Jing Shen,
Li Qi,
Fang Liu,
Liyan Lv,
Yue Li,
Qingwei Meng,
Junning Liu,
Lihua Shang,
and Yan Yu
|
| 4845-4846 |
